Shentracon Chemicals share split: board meet July 28, 2026

What the company has announced

Shentracon Chemicals Limited has scheduled a Board of Directors meeting for July 28, 2026 to consider the sub-division (split) of its existing equity shares. The company said the proposal is aimed at altering its capital structure, and the board’s decision will determine the specific ratio and manner in which the split, if approved, would be executed. The disclosure has been made under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company also clarified that the proposed alteration of capital is subject to approvals. It will require shareholder approval and any regulatory approvals as applicable under the Companies Act, 2013. The share sub-division is being evaluated under Section 61(1)(d) of the Companies Act, 2013.

Board agenda and regulatory framework

The stated agenda for the July 28, 2026 meeting is the sub-division or split of equity shares. Under Section 61(1)(d) of the Companies Act, 2013, companies can alter their share capital by subdividing shares, subject to compliance and member approval. Shentracon Chemicals indicated that member approval is required before implementation, in line with applicable provisions.

In practical terms, the board meeting will decide the split structure, but the split cannot take effect solely based on the board’s decision. The company has explicitly linked implementation to shareholder and regulatory approvals, which typically implies subsequent steps such as convening a general meeting and completing stock exchange and depository-related processes, if applicable.

Trading window closure for designated persons

Alongside the board meeting intimation, Shentracon Chemicals closed its trading window for dealing in the company’s securities for all designated persons and their immediate relatives. The company said the closure is in line with its Code of Conduct for Prevention of Insider Trading.

As disclosed, the trading window closure is effective from July 23, 2026 and will remain closed until 48 hours after the conclusion of the board meeting. This means designated persons are restricted from trading during the period when unpublished price sensitive information could exist around the board’s deliberations.

Key details at a glance

Registrar and Share Transfer Agent (RTA) change: what investors need to know

In a separate set of updates, Shentracon Chemicals has appointed Purva Sharegistry (India) Private Limited as its new Registrar and Share Transfer Agent (RTA) effective June 29, 2026. The company said shareholders should now direct communications to the new RTA.

The move follows corporate changes involving the outgoing RTA. The transition was linked to the amalgamation of the former RTA, C B Management Services Private Limited. The company also referenced the amalgamation of C B Management Services Private Limited with MUFG Intime India Private Limited, effective May 8, 2026.

Earlier, Shentracon Chemicals had disclosed to BSE that its board, at a meeting held on May 5, 2026, approved changing the RTA from C B Management Services Private Limited to Purva Sharegistry (India) Private Limited. At that time, the company indicated the effective date would be communicated after execution of definitive agreements and completion of processes, and that the outgoing RTA would continue until full data and connectivity transition was complete.

New RTA contact details

Financial results publication: audited FY26 standalone numbers

Shentracon Chemicals also submitted copies of newspaper advertisements relating to its audited standalone financial results for the quarter and year ended March 31, 2026. The company stated that these results were approved by the Board on May 30, 2026 and published on May 31, 2026 in the Financial Express and Duranta Barta.

This disclosure matters for investors tracking compliance and information dissemination, as publication in newspapers is one of the formal channels used by listed companies for certain communications.

Office changes in 2026: registered office and corporate office

The company has made multiple location-related disclosures in 2026. On March 18, 2026, Shentracon Chemicals announced that its board approved shifting the registered office within Kolkata. The registered office address was to move from 6A, Kiran Shankar Roy Road, Kolkata – 700001, West Bengal to 21, Ganesh Chandra Avenue, 5th Floor, Dharmatala, Kolkata – 700013, West Bengal.

Along with this shift, the company updated its contact details. The email changed from investor@shentracon.com to info.shentracon@gmail.com, and the contact number changed from 2248-9731 to +91 88282 68721. The website was stated as unchanged (www.shentracon.com).

Separately, the board approved establishing a new corporate office in Mumbai for operational efficiency and administrative convenience. The March 27, 2026 board meeting, chaired by Managing Director Amit Lalit Jain, approved the corporate office at Flat 1910, 19th Floor, 9 Business Bay, Khakhar Property, behind Evershine Mall, Chincholi Bunder, Malad (W), Mumbai 400064, Maharashtra. The company clarified there was no change in the registered office as part of that corporate office decision.

Why the July 28 decision matters for shareholders

A share split does not change a company’s underlying business on its own, but it alters the number of shares and the face value per share based on the ratio approved. In Shentracon Chemicals’ case, the company has not disclosed the ratio yet, and it will depend on the board’s decision at the July 28, 2026 meeting.

For shareholders, the key watchpoints are the board outcome, the next steps for shareholder approval, and the timelines the company provides for implementation if the proposal is taken forward. The continuation of the trading window closure for designated persons until 48 hours after the meeting also signals that the company is treating the board agenda as price sensitive.

Conclusion

Shentracon Chemicals’ July 28, 2026 board meeting will decide whether to proceed with an equity share sub-division and, if so, the specific split ratio and structure. Any implementation will require shareholder and regulatory approvals under the Companies Act, 2013. Investors also have parallel operational updates to track, including the RTA transition to Purva Sharegistry effective June 29, 2026 and the company’s office and contact-detail changes disclosed during 2026.